Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dermatology

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 451 articles:
HTML format
Text format



Single Articles


    October 2018
  1. DESCHAMPS O, Ram-Wolff C, Beylot-Barry M, Grange F, et al
    Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma.
    Br J Dermatol. 2018 Oct 9. doi: 10.1111/bjd.17269.
    PubMed     Text format     Abstract available


  2. ZILL JM, Christalle E, Tillenburg N, Mrowietz U, et al
    Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis.
    Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17272.
    PubMed     Text format     Abstract available


  3. PILKINGTON SM, Barron MJ, Watson REB, Griffiths CEM, et al
    Aged human skin accumulates mast cells with altered functionality which localise to macrophage and VIP(+) nerve fibres.
    Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17268.
    PubMed     Text format     Abstract available


  4. HEFEZ L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, et al
    Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients.
    Br J Dermatol. 2018 Oct 3. doi: 10.1111/bjd.17267.
    PubMed     Text format     Abstract available


  5. PLUMPTRE I, Stuart G, Cerullo A, Kinsler V, et al
    Use of sedation instead of general anaesthesia for screening MRI in congenital melanocytic naevi under the age of 1 year is a successful, safe, and economical first line approach.
    Br J Dermatol. 2018 Oct 3. doi: 10.1111/bjd.17263.
    PubMed     Text format     Abstract available


    September 2018
  6. SAMPOGNA F, Puig L, Spuls P, Girolomoni G, et al
    Reversibility of alexithymia with effective treatment of moderate to severe psoriasis: longitudinal data from EPIDEPSO.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17259.
    PubMed     Text format     Abstract available


  7. TARAZI M, Gaffney RG, Pearson D, Kushner CJ, et al
    Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17257.
    PubMed     Text format     Abstract available


  8. YAN JJ, Qiao M, Li RH, Zhao XT, et al
    Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17256.
    PubMed     Text format     Abstract available


  9. DEENEN NJ, Koens L, Jaspars EH, Vermeer MH, et al
    Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Br J Dermatol. 2018 Sep 27. doi: 10.1111/bjd.17252.
    PubMed     Text format     Abstract available


  10. KOREKAWA A, Akasaka E, Rokunohe D, Fukui T, et al
    Nagashima-type palmoplantar keratoderma and malignant melanoma in Japanese patients.
    Br J Dermatol. 2018 Sep 26. doi: 10.1111/bjd.17251.
    PubMed     Text format     Abstract available


  11. ROGIERS A, Thomas D, Vander Borght S, van den Oord JJ, et al
    Dabrafenib plus trametinib in BRAF K601E-mutant melanoma.
    Br J Dermatol. 2018 Sep 24. doi: 10.1111/bjd.17250.
    PubMed     Text format     Abstract available


  12. PATEL K, Singam V, Vakharia PP, Chopra R, et al
    Measurement properties of three assessments of burden used in atopic dermatitis in adults.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17243.
    PubMed     Text format     Abstract available


  13. MARANO AL, Clarke JM, Morse MA, Shah A, et al
    Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death (PD)-1 therapy.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17245.
    PubMed     Text format     Abstract available


  14. LIOPYRIS K, Navarrete-Dechent C, Yelamos O, Marchetti MA, et al
    Clinical, dermoscopic and reflectance confocal microscopy characterization of facial basal cell carcinomas presenting as small white lesions on sun-damaged skin.
    Br J Dermatol. 2018 Sep 21. doi: 10.1111/bjd.17241.
    PubMed     Text format     Abstract available


  15. EGEBERG A, Thyssen JP, Wu JJ, Skov L, et al
    Risk of first-time and recurrent depression in patients with psoriasis - a population-based cohort study.
    Br J Dermatol. 2018 Sep 19. doi: 10.1111/bjd.17208.
    PubMed     Text format     Abstract available


  16. REDDY N, Nguyen BT
    The utility of optical coherence tomography for diagnosis of basal cell carcinoma: A quantitative review.
    Br J Dermatol. 2018 Sep 14. doi: 10.1111/bjd.17201.
    PubMed     Text format     Abstract available


  17. XU S, Stump TK, Jain J, Alshurafa N, et al
    Variation in daily ultraviolet light exposure and sun protection behaviours of melanoma survivors: an observational single-arm pilot study with a wearable sensor.
    Br J Dermatol. 2018 Sep 12. doi: 10.1111/bjd.17196.
    PubMed     Text format     Abstract available


  18. PAPP KA, Gooderham M, Jenkins R, Vender R, et al
    GM-CSF as a therapeutic target in psoriasis: randomised, controlled investigation using namilumab - a specific, human anti-GM-CSF monoclonal antibody.
    Br J Dermatol. 2018 Sep 12. doi: 10.1111/bjd.17195.
    PubMed     Text format     Abstract available


  19. VAN LEE CB, Roorda BM, Wakkee M, Voorham Q, et al
    Recurrence rate of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery versus standard excision: a retrospective cohort study.
    Br J Dermatol. 2018 Sep 10. doi: 10.1111/bjd.17188.
    PubMed     Text format     Abstract available


  20. SCHREINER M, Baumler W, Eckl D, Spath A, et al
    Photodynamic inactivation of bacteria to decolonize Methicillin resistant Staphylococcus aureus (MRSA) from human skin.
    Br J Dermatol. 2018 Sep 7. doi: 10.1111/bjd.17152.
    PubMed     Text format     Abstract available


  21. LARSABAL M, Ly S, Sbidian E, Moyal-Barracco M, et al
    "GENIPSO": a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17147.
    PubMed     Text format     Abstract available


  22. STROBER BE, Gottlieb AB, van de Kerkhof PCM, Puig L, et al
    Benefit-risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17149.
    PubMed     Text format     Abstract available


  23. SCHAUER F, Kern JS, Virtic O, Technau-Hafsi K, et al
    A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17146.
    PubMed     Text format     Abstract available


  24. GISONDI P, Bianchi L, Calzavara-Pinton P, Conti A, et al
    Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17133.
    PubMed     Text format     Abstract available


  25. WANG X, Wang A, Wang X, Li R, et al
    Cutaneous Mucormycosis caused by Mucor irregularis in a patient with CARD9 deficiency.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17144.
    PubMed     Text format     Abstract available


  26. BRANCACCIO G, Napolitano S, Troiani T, Franco R, et al
    Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17145.
    PubMed     Text format     Abstract available


  27. THIESEN I, Wehkamp U, Bruggemann M, Ritgen M, et al
    Skin involvement by chronic lymphocytic leukemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17135.
    PubMed     Text format     Abstract available


  28. MATTHEWS NH, Risica PM, Ferris LK, Beatson M, et al
    Psychosocial impact of skin biopsies in the setting of melanoma screening - A cross-sectional survey.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17134.
    PubMed     Text format     Abstract available


  29. ALBRECHT S, Jung S, Muller R, Lademann J, et al
    Skin type differences in solar simulated radiation-induced oxidative stress.
    Br J Dermatol. 2018 Sep 3. doi: 10.1111/bjd.17129.
    PubMed     Text format     Abstract available


  30. GKOGKOLOU P, Sarna M, Sarna T, Paus R, et al
    Protection of glucotoxicity by a tripeptide derivative of alpha-melanocyte-stimulating hormone in human epidermal keratinocytes.
    Br J Dermatol. 2018 Sep 1. doi: 10.1111/bjd.17125.
    PubMed     Text format     Abstract available


  31. SIMON M
    Effects of environmental skin stressors on filaggrin degradation products: importance for eczema.
    Br J Dermatol. 2018;179:560-561.
    PubMed     Text format    


  32. PASSI A
    Hyaluronan is a key regulator of skin homeostasis and wound healing.
    Br J Dermatol. 2018;179:558-559.
    PubMed     Text format    


  33. HAUG V, Schilling B
    Programmed death-1 blockade for multiple basal cell carcinomas: clearing the field systemically?
    Br J Dermatol. 2018;179:566-567.
    PubMed     Text format    


  34. TOBIN DJ
    Early evidence for opposing effects of full versus fragmented adiponectin on melanogenesis in human epidermal melanocytes.
    Br J Dermatol. 2018;179:561-562.
    PubMed     Text format    


    August 2018
  35. LEONARDI C, Papp K, Strober B, Thaci D, et al
    Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis.
    Br J Dermatol. 2018 Aug 31. doi: 10.1111/bjd.17084.
    PubMed     Text format     Abstract available


  36. LIU NF, Yu ZY, Lou Y, Sun D, et al
    A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Br J Dermatol. 2018 Aug 31. doi: 10.1111/bjd.17120.
    PubMed     Text format     Abstract available


  37. WARREN RB, Marsden A, Tomenson B, Mason KJ, et al
    Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.
    Br J Dermatol. 2018 Aug 28. doi: 10.1111/bjd.16776.
    PubMed     Text format     Abstract available


  38. KOGUCHI-YOSHIOKA H, Watanabe R, Fujisawa Y, Ishitsuka Y, et al
    Skin resident memory T cell population is not effectively constructed in systemic sclerosis.
    Br J Dermatol. 2018 Aug 18. doi: 10.1111/bjd.17100.
    PubMed     Text format     Abstract available


  39. IGHANI A, Georgakopoulos JR, Shear NH, Walsh S, et al
    Long-term 52-week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series.
    Br J Dermatol. 2018 Aug 18. doi: 10.1111/bjd.17099.
    PubMed     Text format     Abstract available


  40. GROOT J, Nybo Andersen AM, Adam A, Tind Nielsen TE, et al
    Associations between maternal socioeconomic position and psoriasis: A cohort study among the offspring of the Danish National Birth Cohort.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17091.
    PubMed     Text format     Abstract available


  41. NAVASIOLAVA N, Gnanou M, Douillard M, Saulnier P, et al
    The Extent of PXE Skin Changes is Related to Cardiovascular Complications and Visual Loss: a Cross-sectional Study.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17094.
    PubMed     Text format     Abstract available


  42. FOGARTY GB, McLaren KR, Moutrie Z, Poon TSC, et al
    Locally advanced skin cancers of the frail and elderly - consider adaptive split course radiotherapy (ASCRT).
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17037.
    PubMed     Text format     Abstract available


  43. HUET F, Dion A, Batardiere A, Nedelec AS, et al
    Sensitive skin can be small fiber neuropathy: Results from a case-control quantitative sensory testing study.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17082.
    PubMed     Text format     Abstract available


  44. WATSON N, Wu K, Farr P, Reynolds N, et al
    Ustekinumab Exposure during Conception and Pregnancy in Patients with Chronic Plaque Psoriasis - a case series of 10 pregnancies.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17086.
    PubMed     Text format     Abstract available


  45. CUST AE, Aitken J, Baade P, Whiteman D, et al
    Why a randomised melanoma screening trial may be a good idea.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17089.
    PubMed     Text format     Abstract available


  46. FERTITTA L, Sicre de Fontbrune F, Battistella M, De Masson A, et al
    Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17081.
    PubMed     Text format     Abstract available


  47. CLASSEN A, Buhl T, Schubert S, Worm M, et al
    The frequency of specific contact allergies is reduced in psoriasis patients.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17080.
    PubMed     Text format     Abstract available


  48. TSAI TY, Yen H, Huang YC
    Serum homocysteine, folate, and vitamin B12 levels in patients with psoriasis: A systematic review and meta-analysis.
    Br J Dermatol. 2018 Aug 3. doi: 10.1111/bjd.17034.
    PubMed     Text format     Abstract available


  49. YIU ZZN, Ashcroft DM, Evans I, McElhone K, et al
    Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17036.
    PubMed     Text format     Abstract available


  50. CLAUSEN ML, Edslev SM, Norreslet LB, Sorensen JA, et al
    Temporal Variation of Staphylococcus aureus clonal complexes in Atopic Dermatitis - a follow up study.
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17033.
    PubMed     Text format     Abstract available


  51. THOMAS KS
    Could we be doing more to provide an evidence base for rare skin conditions?
    Br J Dermatol. 2018;179:240-241.
    PubMed     Text format    


  52. PROKSCH E
    Lowering skin pH: improved barrier function, anti-ageing and beyond.
    Br J Dermatol. 2018;179:254-255.
    PubMed     Text format    


  53. GJERSVIK P
    Biologics: targeting systemic inflammation in psoriasis.
    Br J Dermatol. 2018;179:247-248.
    PubMed     Text format    


  54. TOWER RL
    Kaposiform haemangioendothelioma: new insights and old problems.
    Br J Dermatol. 2018;179:253-254.
    PubMed     Text format    


  55. MONTGOMERY K, Thompson AR
    Developing sensitivity to the psychological burden associated with skin conditions: a call for training.
    Br J Dermatol. 2018;179:237-238.
    PubMed     Text format    


  56. VAN DOORN R
    Methylation marks melanoma metastasis.
    Br J Dermatol. 2018;179:250-251.
    PubMed     Text format    


  57. THYSSEN JP
    The trade-off: evolutionary benefits of epidermal filaggrin deficiency on cheek skin came at the price of the atopic dermatitis epidemic.
    Br J Dermatol. 2018;179:235-236.
    PubMed     Text format    


  58. WALSH S, Creamer D
    Severe cutaneous adverse reactions syndromes and prescribing autonomy.
    Br J Dermatol. 2018;179:242-243.
    PubMed     Text format    


  59. CAHOON EK
    Repurposing clinical trial data for skin cancer aetiology.
    Br J Dermatol. 2018;179:243-244.
    PubMed     Text format    


  60. MELLODY KT, Horn J, Watson REB
    Heterogenity of dermal fibroblasts: skin equivalent models that aim to recreate the cutaneous microenvironment.
    Br J Dermatol. 2018;179:248-250.
    PubMed     Text format    


  61. KIRBY B, Lynch M
    Adipokines and psoriasis: the obesity link.
    Br J Dermatol. 2018;179:239.
    PubMed     Text format    


    July 2018
  62. KUSHNER CJ, Tarazi M, Gaffney RG, Feng R, et al
    Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric dermatologists and rheumatologists.
    Br J Dermatol. 2018 Jul 23. doi: 10.1111/bjd.17012.
    PubMed     Text format     Abstract available


  63. KANZAKI A, Kato Y, Kariya T, Kanda Y, et al
    Basal cell carcinoma response to imiquimod was associated with the Gli1/Gli3 expression ratio.
    Br J Dermatol. 2018 Jul 17. doi: 10.1111/bjd.17015.
    PubMed     Text format     Abstract available


  64. POLUBOTHU S, Glover M, Holder SE, Kinsler VA, et al
    Uniparental disomy as a mechanism for CERS3-mutated autosomal recessive congenital ichthyosis.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.16999.
    PubMed     Text format     Abstract available


  65. PARISI R, Webb RT, Kleyn CE, Carr MJ, et al
    Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17004.
    PubMed     Text format     Abstract available


  66. CONNOLLY A, Grandi V, Stefanato CM, Palmer R, et al
    Primary cutaneous CD30(+) anaplastic large cell lymphoma associated with fingolimod.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17003.
    PubMed     Text format     Abstract available


  67. PAPIER K, Gordon LG, Khosrotehrani K, Isbel N, et al
    Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.
    Br J Dermatol. 2018 Jul 13. doi: 10.1111/bjd.17001.
    PubMed     Text format     Abstract available


  68. HULSHOF L, Hack DP, Hasnoe QCJ, Dontje B, et al
    Stratum corneum analysis provide a minimal invasive tool to study immune response and skin barrier in atopic dermatitis children.
    Br J Dermatol. 2018 Jul 10. doi: 10.1111/bjd.16994.
    PubMed     Text format     Abstract available


  69. CHIJIWA C, Takeoka S, Kamata M, Uchida H, et al
    Secukinumab decreases the serum KL-6 level in psoriasis patients with elevated serum KL-6 level.
    Br J Dermatol. 2018 Jul 9. doi: 10.1111/bjd.16993.
    PubMed     Text format     Abstract available


  70. THYSSEN JP, Egeberg A
    Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16939.
    PubMed     Text format     Abstract available


  71. TSAKOK T, Woolf R, Smith CH, Weidinger S, et al
    Atopic dermatitis: the skin barrier and beyond.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16934.
    PubMed     Text format     Abstract available


  72. RENCZ F, Gulacsi L, Pentek M, Poor AK, et al
    Proposal of a new scoring formula for the DLQI in psoriasis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16927.
    PubMed     Text format     Abstract available


  73. BRANDWEIN M, Fuks G, Israel A, Nejman D, et al
    Identification of a unique Staphylococcus aureus ribosomal signature in severe atopic dermatitis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16936.
    PubMed     Text format     Abstract available


  74. GUNN DA
    Histone H3 acetylation is a conduit of gene expression perturbations in photodamaged skin.
    Br J Dermatol. 2018;179:10-11.
    PubMed     Text format    


  75. GISONDI P
    The multidimensional burden of psoriasis.
    Br J Dermatol. 2018;179:13-14.
    PubMed     Text format    


  76. MAYBURY CM, Di Meglio P, Smith CH
    Aldara-induced dermatitis is associated with development of liver fibrosis in mice.
    Br J Dermatol. 2018;179:9-10.
    PubMed     Text format    


  77. POWELL J, Badminton M
    Shedding light on recent advances in our understanding of cutaneous porphyrias.
    Br J Dermatol. 2018;179:1-2.
    PubMed     Text format    


  78. NOBILI V
    Liver-skin axis: a new view or viewed already?
    Br J Dermatol. 2018;179:6.
    PubMed     Text format    


    June 2018
  79. AHLSTROM MG, Thyssen JP, Menne T, Midander K, et al
    Short contact with nickel causes allergic contact dermatitis: an experimental study.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16935.
    PubMed     Text format     Abstract available


  80. ZHAO J, Zhang X, Sun H, An R, et al
    Is psoriasis a risk factor of angiography-proven coronary artery disease?
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16925.
    PubMed     Text format     Abstract available


  81. JOLY-TONETTI N, Wibawa JID, Bell M, Tobin DJ, et al
    An explanation for the mysterious distribution of melanin in human skin - a rare example of asymmetric (melanin) organelle distribution during mitosis of basal layer progenitor keratinocytes.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16926.
    PubMed     Text format     Abstract available


  82. FUJISAWA Y, Otomo Y, Ogata Y, Nakamura Y, et al
    Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis.
    Br J Dermatol. 2018 Jun 28. doi: 10.1111/bjd.16924.
    PubMed     Text format     Abstract available


  83. HARMS FL, Nampoothiri S, Kortum F, Thomas J, et al
    Coinheritance of biallelic SLURP1 and SLC39A4 mutations cause a severe genodermatosis with skin peeling and hair loss all over the body.
    Br J Dermatol. 2018 Jun 27. doi: 10.1111/bjd.16912.
    PubMed     Text format     Abstract available


  84. SKOV L, Thomsen SF, Kristensen LE, Dodge R, et al
    Cause-specific mortality in patients with psoriasis and psoriatic arthritis.
    Br J Dermatol. 2018 Jun 27. doi: 10.1111/bjd.16919.
    PubMed     Text format     Abstract available


  85. MOCHIZUKI H, Lavery MJ, Nattkemper LA, Albornoz C, et al
    Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16921.
    PubMed     Text format     Abstract available


  86. KALAKI E, Mizara A
    The role of parenting experiences, rather than age of onset or presence of the skin condition, in the development of maladaptive schemas in a community sample of patients with atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16920.
    PubMed     Text format     Abstract available


  87. HURAULT G, Schram ME, Roekevisch E, Spuls PI, et al
    Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16916.
    PubMed     Text format     Abstract available


  88. HABJANIC N, Koytchev R, Yankova R, Kerec-Kos M, et al
    Therapeutic equivalence of two formulations of calcipotriol-betamethasone ointment: a multi-centre, randomized, double-blind study in adult patients with chronic plaque psoriasis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16913.
    PubMed     Text format     Abstract available


  89. TINA E, Prosen S, Lennholm S, Gasparyan G, et al
    Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma.
    Br J Dermatol. 2018 Jun 25. doi: 10.1111/bjd.16905.
    PubMed     Text format     Abstract available


  90. GOUSSOT R, Frances C, Cury K, Bessis D, et al
    Prospective evaluation of frequency of genital lichen sclerosus in 79 patients with systemic sclerosis.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16898.
    PubMed     Text format     Abstract available


  91. VAN EGMOND S, Wakkee M, Droger M, Bastiaens MT, et al
    Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16900.
    PubMed     Text format     Abstract available


  92. WARREN RB, Reich K, Langley RG, Strober B, et al
    Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16901.
    PubMed     Text format     Abstract available


  93. NARANG T, Kumar S, Handa S, Dogra S, et al
    Hydroxyurea and Acitretin as a novel combination therapy in severe plaque psoriasis.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16899.
    PubMed     Text format     Abstract available


  94. EATON LH, Dearman RJ, Kimber I, Griffiths CEM, et al
    Keratinocytes derived from late-onset psoriasis skin do not impair Langerhans cell migration.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16896.
    PubMed     Text format     Abstract available


  95. KEOHANE SG, Proby CM, Newlands C, Motley RJ, et al
    The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, United Kingdom.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16892.
    PubMed     Text format     Abstract available


  96. VAN DER LINDEN M, Schuurman MS, Bulten J, Massuger LFAG, et al
    Stop routine screening for associated malignancies in cutaneous non-invasive vulvar Paget disease?
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16894.
    PubMed     Text format     Abstract available


  97. DRUCKER AM, Flohr C
    Revisiting atopic dermatitis and cardiovascular disease.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16891.
    PubMed     Text format     Abstract available


  98. BLAUVELT A, Lacour JP, Fowler JF Jr, Weinberg JM, et al
    Phase 3 randomised study of the proposed biosimilar adalimumab GP2017 in psoriasis - impact of multiple switches.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16890.
    PubMed     Text format     Abstract available


  99. BOSWELL K, Cameron H, West J, Fleming C, et al
    Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16716.
    PubMed     Text format     Abstract available


  100. FUJISAWA Y, Otomo Y, Ogata Y, Nakamura Y, et al
    Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16826.
    PubMed     Text format     Abstract available


  101. SNEKVIK I, Nilsen TIL, Romundstad PR, Saunes M, et al
    Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16885.
    PubMed     Text format     Abstract available


  102. FARAH M, Nagarajan P, Curry JL, Tang Z, et al
    Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia.
    Br J Dermatol. 2018 Jun 13. doi: 10.1111/bjd.16881.
    PubMed     Text format     Abstract available


  103. HALVORSEN JA, Loberg M, Gjersvik P, Roscher I, et al
    Why a randomized melanoma screening trial is not a good idea.
    Br J Dermatol. 2018 Jun 12. doi: 10.1111/bjd.16784.
    PubMed     Text format    


  104. COLLIER NJ, Haylett AK, Wong TH, Morton CA, et al
    Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Br J Dermatol. 2018 Jun 11. doi: 10.1111/bjd.16838.
    PubMed     Text format     Abstract available


  105. HESSELVIG JH, Egeberg A, Kofoed K, Gislason G, et al
    Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Br J Dermatol. 2018 Jun 9. doi: 10.1111/bjd.16831.
    PubMed     Text format     Abstract available


  106. PAPIER K, Gordon LG, Khosrotehrani K, Isbel N, et al
    Increase in preventive behaviour by organ transplant recipients after sun protection information in a skin cancer surveillance clinic.
    Br J Dermatol. 2018 Jun 8. doi: 10.1111/bjd.16836.
    PubMed     Text format     Abstract available


  107. FAVRE B, Begre N, Borradori L
    A recessive mutation in the DSP gene linked to cardiomyopathy, skin fragility and hair defects impairs the binding of desmoplakin to epidermal keratins and the muscle-specific intermediate filament desmin.
    Br J Dermatol. 2018 Jun 7. doi: 10.1111/bjd.16832.
    PubMed     Text format     Abstract available


  108. PODLIPNIK S, Moreno-Ramirez D, Carrera C, Barreiro A, et al
    Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with AJCC stage IIB, IIC and III malignant melanoma.
    Br J Dermatol. 2018 Jun 7. doi: 10.1111/bjd.16833.
    PubMed     Text format     Abstract available


  109. MIOLA AC, Roio EF, Lima TRR, Schmitt JV, et al
    Effectiveness and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis and skin field cancerisation of the forearms: a randomized controlled trial.
    Br J Dermatol. 2018 Jun 3. doi: 10.1111/bjd.16824.
    PubMed     Text format     Abstract available


  110. STENEHJEM JS, Veierod MB, Nilsen LT, Ghiasvand R, et al
    Anthropometric factors and Breslow thickness: Prospective data on 2570 cutaneous melanoma cases in the population-based Janus Cohort.
    Br J Dermatol. 2018 Jun 1. doi: 10.1111/bjd.16825.
    PubMed     Text format     Abstract available


  111. VON KOBYLETZKI LB, Svensson A
    Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
    Br J Dermatol. 2018;178:1236-1237.
    PubMed     Text format    


  112. KIM Y, Kraft P, Asgari MM
    Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer.
    Br J Dermatol. 2018;178:1241-1242.
    PubMed     Text format    


  113. SEDDON O, Hughes H
    Staphylococcus aureus and atopic dermatitis: a complex relationship.
    Br J Dermatol. 2018;178:1234.
    PubMed     Text format    


  114. YU H, Li R, Yue Y, Li A, et al
    Image Gallery: Skin lesions from jellyfish stings.
    Br J Dermatol. 2018;178:e393.
    PubMed     Text format    


  115. KIRBY B
    Langerhans cells in psoriasis: getting to the core of the disease.
    Br J Dermatol. 2018;178:1240.
    PubMed     Text format    


  116. OFENLOCH RF
    Incontinence-associated dermatitis: a consensus on its severity assessment.
    Br J Dermatol. 2018;178:1238-1239.
    PubMed     Text format    


  117. DRUCKER AM, Flohr C
    Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?
    Br J Dermatol. 2018;178:1235-1236.
    PubMed     Text format    


  118. BALIEVA F
    Psoriasis has a huge impact on teenagers.
    Br J Dermatol. 2018;178:1243.
    PubMed     Text format    


    May 2018
  119. GONNET J, Perrin H, Hutton AJ, Boccara D, et al
    Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model.
    Br J Dermatol. 2018 May 28. doi: 10.1111/bjd.16721.
    PubMed     Text format     Abstract available


  120. LIN YK, Lee BH
    Does Lindioil (Indirubin) treatment affect the composition of Malassezia species on psoriatic skin?
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16810.
    PubMed     Text format     Abstract available


  121. SBIDIAN E, Mezzarobba M, Weill A, Coste J, et al
    Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naive patients from the French national health insurance database (SNIIRAM).
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16809.
    PubMed     Text format     Abstract available


  122. GAITANIS G, Magiatis P, Velegraki A, Bassukas ID, et al
    A traditional Chinese remedy points to a natural skin habitat: Indirubin (indigo naturalis) for psoriasis and the Malassezia metabolome.
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16807.
    PubMed     Text format     Abstract available


  123. VALENZUELA F, Korman NJ, Bissonnette R, Bakos N, et al
    Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.
    Br J Dermatol. 2018 May 21. doi: 10.1111/bjd.16798.
    PubMed     Text format     Abstract available


  124. BRUNET-POSSENTI F, Charpentier C, Collin G, Descamps D, et al
    Impact of anti-IL-17 treatment on cutaneous and genital HPV infection.
    Br J Dermatol. 2018 May 19. doi: 10.1111/bjd.16799.
    PubMed     Text format     Abstract available


  125. WAN MT, Ming ME
    Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16785.
    PubMed     Text format     Abstract available


  126. CHRISTENSEN L, Cooper K, Honda K, Mansur D, et al
    Relapse rates in patients with unilesional primary cutaneous B cell lymphoma treated with radiation therapy: a single-institution experience.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16783.
    PubMed     Text format     Abstract available


  127. ZHU TH, Zhu TR, Tran KA, Sivamani RK, et al
    Epithelial Barrier Dysfunctions in Atopic Dermatitis: A Skin-Gut-Lung Model Linking Microbiome Alteration and Immune Dysregulation.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16734.
    PubMed     Text format     Abstract available


  128. CAYUELA A, Cayuela L, Rodriguez-Dominguez S, Lorente AI, et al
    Is melanoma mortality declining in Spain? Analysis of trends 1975-2016.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16777.
    PubMed     Text format     Abstract available


  129. PILKINGTON SM, Dearman RJ, Kimber I, Griffiths CEM, et al
    Langerhans cells express human beta defensin-3: relevance for immunity during skin ageing.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16770.
    PubMed     Text format     Abstract available


  130. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Assessment of Treatment-Seeking Behaviour in Patients with Psoriasis.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16778.
    PubMed     Text format     Abstract available


  131. MOAWAD S, Reigneau M, de la Fouchardiere A, Soufir N, et al
    Clinical, dermoscopic, histological and molecular analysis of BAP1 inactivated melanocytic nevus/tumor in two familial cases of BAP1 syndrome.
    Br J Dermatol. 2018 May 13. doi: 10.1111/bjd.16740.
    PubMed     Text format     Abstract available


  132. EL KHOURY M, Assier H, Gener G, Paul M, et al
    Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin, and pristinamycin: clinical history and patch testing.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16738.
    PubMed     Text format     Abstract available


  133. RYAN C, Menter A, Guenther L, Blauvelt A, et al
    Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16736.
    PubMed     Text format     Abstract available


  134. KIMBALL AB, Augustin M, Gordon KB, Krueger GG, et al
    Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16737.
    PubMed     Text format     Abstract available


  135. BLAUVELT A, Reich K, Papp KA, Kimball AB, et al
    Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomised Controlled Trials.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16724.
    PubMed     Text format     Abstract available


  136. WEHNER MR, Dalma N, Landefeld C, Pare-Anastasiadou A, et al
    Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16730.
    PubMed     Text format     Abstract available


  137. FUJISAWA Y
    Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors.
    Br J Dermatol. 2018 May 7. doi: 10.1111/bjd.16689.
    PubMed     Text format    


  138. HARKINS CP, McAleer MA, Bennett D, McHugh M, et al
    The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients.
    Br J Dermatol. 2018 May 5. doi: 10.1111/bjd.16722.
    PubMed     Text format     Abstract available


  139. SU KA, Habel LA, Achacoso NS, Friedman GD, et al
    Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16713.
    PubMed     Text format     Abstract available


  140. GARCIA-DOVAL I, Descalzo MA, Mason KJ, Cohen AD, et al
    Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16715.
    PubMed     Text format     Abstract available


  141. DODOO-SCHITTKO F
    Psoriasis: the significance of psychological stress.
    Br J Dermatol. 2018;178:1002.
    PubMed     Text format    


  142. ERGEN EN, Donaldson SL, Stratton MS, Pavlidakey PG, et al
    Image Gallery: Molluscum contagiosum-like facial lesions in a patient with a renal transplant: deep dermatophytosis due to Trichophyton rubrum.
    Br J Dermatol. 2018;178:e328.
    PubMed     Text format    


  143. GOMEZ MOYANO E, Vera-Casano A, Ayala-Blanca M, Martinez-Pilar L, et al
    Image Gallery: Cutaneous findings in Hunter syndrome.
    Br J Dermatol. 2018;178:e329.
    PubMed     Text format    


  144. KRAEMER KH, Tamura D, Khan SG
    Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.
    Br J Dermatol. 2018;178:1009.
    PubMed     Text format    


  145. ROSSI AM, Navarrete-Dechent C, Nehal KS
    Beyond skin deep: taking bedside dermatology to the next level with noninvasive technologies.
    Br J Dermatol. 2018;178:994-996.
    PubMed     Text format    


  146. LI BS, Cary JH, Maibach HI
    Cutaneous biometrics: guidelines and models.
    Br J Dermatol. 2018;178:1008-1009.
    PubMed     Text format    


  147. BRAY N, Wolf P
    Allocation of biologics: health economics and clinical decision making in plaque psoriasis.
    Br J Dermatol. 2018;178:997-998.
    PubMed     Text format    


  148. DARRIGADE AS, Boniface K, Seneschal J
    Inflammatory skin eruptions induced by anti-tumour necrosis factor-alpha therapy differ undeniably from psoriasis or eczema.
    Br J Dermatol. 2018;178:1007-1008.
    PubMed     Text format    


  149. PAUL C
    Ixekizumab or secukinumab in psoriasis: what difference does it make?
    Br J Dermatol. 2018;178:1003-1005.
    PubMed     Text format    


  150. SCHALKWIJK J
    A role for the microbiome in psoriasis?
    Br J Dermatol. 2018;178:999-1000.
    PubMed     Text format    


  151. SCHMITT J
    After the approval of dupilumab for moderate-to-severe atopic dermatitis: what is next on the research agenda?
    Br J Dermatol. 2018;178:992-993.
    PubMed     Text format    


    April 2018
  152. DARRIGADE AS, Legrand A, Andreu N, Jacquemin C, et al
    Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16711.
    PubMed     Text format     Abstract available


  153. MIYAZAWA H, Fujita Y, Iwata H, Ishikawa Y, et al
    Two cases of generalized pustular psoriasis complicated with IgG4-related disease.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16712.
    PubMed     Text format     Abstract available


  154. TETU P, Monfort JB, Barbaud A, Frances C, et al
    Failure of Rituximab in refractory erosive lichen planus.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16704.
    PubMed     Text format     Abstract available


  155. BAN L, Labbouz S, Grindlay D, Batchelor J, et al
    Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16703.
    PubMed     Text format     Abstract available


  156. WANG R, Song Y, Du M, Yang E, et al
    Skin microbiome changes in patients with interdigital tinea pedis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16706.
    PubMed     Text format     Abstract available


  157. RAUWERDINK DJW, Roach REJ, Etty M, Kukutsch NA, et al
    Melanoma diagnosis during periodic surveillance of patients with multiple atypical naevi.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16708.
    PubMed     Text format     Abstract available


  158. COSTANZO A, Bianchi L, Flori ML, Malara G, et al
    Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16705.
    PubMed     Text format     Abstract available


  159. JENSEN P, Zachariae C, Skov L, Zachariae R, et al
    Sleep disturbance in psoriasis - a case-controlled study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16702.
    PubMed     Text format     Abstract available


  160. FOO SH, Nightingale PG, Gazzani P, Bader E, et al
    A 10 year longitudinal follow up study of a UK paediatric transplant population to assess for skin cancer.
    Br J Dermatol. 2018 Apr 27. doi: 10.1111/bjd.16697.
    PubMed     Text format     Abstract available


  161. MCALEER MA, Jakasa I, Raj N, O'Donnell CPF, et al
    Early life regional and temporal variation in filaggrin-derived natural moisturising factor, filaggrin processing enzyme activity, corneocyte phenotypes and plasmin activity: Implications for atopic dermatitis.
    Br J Dermatol. 2018 Apr 25. doi: 10.1111/bjd.16691.
    PubMed     Text format     Abstract available


  162. NARBUTT J, Philipsen PA, Lesiak A, Liljendahl TS, et al
    Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25(OH)D3 , after a summer holiday in Northern Europe.
    Br J Dermatol. 2018 Apr 24. doi: 10.1111/bjd.16668.
    PubMed     Text format     Abstract available


  163. CHALMERS JR, Thomas KS, Apfelbacher C, Williams HC, et al
    Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16543.
    PubMed     Text format     Abstract available


  164. EGEBERG A, Skov L
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors.
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16690.
    PubMed     Text format    


  165. FUJIMURA T, Sato Y, Kambayashi Y, Tanita K, et al
    Three cases of advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and CXCL10 as possible biomarkers predicting the biological behaviour of angiosarcoma.
    Br J Dermatol. 2018 Apr 17. doi: 10.1111/bjd.16676.
    PubMed     Text format     Abstract available


  166. LANGAN EA, Gratz V, Billmann F, Zillikens D, et al
    Does the gastrointestinal microbiome contribute to the "obesity paradox" in melanoma survival?
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16681.
    PubMed     Text format     Abstract available


  167. CARLAVAN I, Bertino B, Rivier M, Martel P, et al
    Atrophic scar formation in acne patients involves long-acting immune responses with plasma cells and alteration of sebaceous glands.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16680.
    PubMed     Text format     Abstract available


  168. KIM J, Kim YH, Park B, Seo HM, et al
    Multispectral ex vivo photoacoustic imaging of cutaneous melanoma for better selection of the excision margin.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16677.
    PubMed     Text format     Abstract available


  169. VARMA S
    Frequency of squamous cell carcinoma in situ (SCCIS) and SCC in re-excisions of biopsy-proven cutaneous SCCIS.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16674.
    PubMed     Text format     Abstract available


  170. MACHET L, Zaragoza J, Finon A, Garnier M, et al
    Baseline neutrophil to lymphocyte ratio in patients with advanced melanoma treated with immune check point inhibitors.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16675.
    PubMed     Text format     Abstract available


  171. LEE EH, Klassen AF, Cano SJ, Nehal KS, et al
    FACE-Q Skin Cancer Module for Measuring Patient-Reported Outcomes Following Facial Skin Cancer Surgery.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16671.
    PubMed     Text format     Abstract available


  172. SVENDSEN MT, Andersen F, Andersen KH, Pottegard A, et al
    An App Supporting Psoriasis Patients Improves Adherence to Topical Treatment: A randomised controlled trial.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16667.
    PubMed     Text format     Abstract available


  173. MCNOE BM, Reeder AI, de Lange MP
    SunSmart schools: a New Zealand skin cancer primary prevention intervention blueprint for primary school settings.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16670.
    PubMed     Text format     Abstract available


  174. GAN Y, Zhou M, He C, Chen Z, et al
    Lipidomics reveals skin surface lipid abnormity in male youth acne.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16655.
    PubMed     Text format     Abstract available


  175. MENSA E, Recchioni R, Marcheselli F, Giuliodori K, et al
    MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16659.
    PubMed     Text format     Abstract available


  176. THOMPSON AR, Montgomery K
    Stress and more stress: the importance in skin disease of worrying about what others think.
    Br J Dermatol. 2018;178:821-822.
    PubMed     Text format    


  177. OOSTERHAVEN JAF
    Interpretability in atopic dermatitis: all about the anchor.
    Br J Dermatol. 2018;178:832-833.
    PubMed     Text format    


  178. APFELBACHER C
    The Cochrane Skin Group's COUSIN convened for the second time.
    Br J Dermatol. 2018;178:837-838.
    PubMed     Text format    


  179. AKEL R, Fuller C
    Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018;178:823-824.
    PubMed     Text format    


  180. BORRONI RG, Costanzo A
    HLA-C*06 and psoriasis: susceptibility, phenotype, course and response to treatment.
    Br J Dermatol. 2018;178:825.
    PubMed     Text format    


  181. HAAS L, Wiesner T, Obenauf AC
    A new era of proactive melanoma therapy: hit hard, hit early.
    Br J Dermatol. 2018;178:817-820.
    PubMed     Text format    


  182. KEZIC S
    Atopic dermatitis: risk estimates for hand eczema.
    Br J Dermatol. 2018;178:827.
    PubMed     Text format    


  183. MROWIETZ U
    Psoriasis, stress, age and more.
    Br J Dermatol. 2018;178:830-831.
    PubMed     Text format    


    March 2018
  184. JI Y, Yang K, Peng S, Chen S, et al
    Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
    Br J Dermatol. 2018 Mar 30. doi: 10.1111/bjd.16601.
    PubMed     Text format     Abstract available


  185. ANGELOVA-FISCHER I, Fischer TW, Abels C, Zillikens D, et al
    Accelerated barrier recovery and enhancement of the barrier integrity and properties by topical application of a pH 4 compared to a pH 5.8 w/o emulsion in aged skin.
    Br J Dermatol. 2018 Mar 25. doi: 10.1111/bjd.16591.
    PubMed     Text format     Abstract available


  186. VU M, Adler NR, Wee E, Wolfe R, et al
    Impact of naevus association on survival for nodular and superficial spreading melanomas.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16556.
    PubMed     Text format     Abstract available


  187. MAHEVAS T, Bertinchamp R, Battistella M, Reygagne P, et al
    Efficacy of oral sirolimus as salvage therapy in refractory lichen planus associated with immune deficiency.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16555.
    PubMed     Text format     Abstract available


  188. YAN K, Xu W, Huang Y, Zhang Z, et al
    Methotrexate restores the function of peripheral blood Treg cells in psoriasis vulgaris via CD73/AMPK/mTOR pathway.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16560.
    PubMed     Text format     Abstract available


  189. PASSARELLI MN, Barry EL, Zhang D, Gangar P, et al
    Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16571.
    PubMed     Text format     Abstract available


  190. LEE EB, Reynolds KA, Pithadia DJ, Wu JJ, et al
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16572.
    PubMed     Text format     Abstract available


  191. FORSCHNER A, Keim U, Hofmann M, Spankuch I, et al
    Diagnostic accuracy of dermatofluoroscopy in cutaneous melanoma detection: Results of a prospective multicentre clinical study in 476 pigmented lesions.
    Br J Dermatol. 2018 Mar 22. doi: 10.1111/bjd.16565.
    PubMed     Text format     Abstract available


  192. ADAN F, Crijns MB, Zandstra WSE, Bekkenk MW, et al
    Cumulative risk of skin tumours in patients with Lynch syndrome.
    Br J Dermatol. 2018 Mar 15. doi: 10.1111/bjd.16552.
    PubMed     Text format     Abstract available


  193. HANSEN PR, Isaksen JL, Jemec GB, Kanters JK, et al
    Pulmonary function in subjects with psoriasis: A cross-sectional population study.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16539.
    PubMed     Text format     Abstract available


  194. HERNANDEZ-BREIJO B, Jurado T, Rodriguez-Martin E, Martinez-Feito A, et al
    Differential blood cellular profile in patients with moderate to severe psoriasis treated with classical systemic therapies: A step forward in personalised medicine.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16537.
    PubMed     Text format     Abstract available


  195. SCHMITZ L, Gambichler T, Kost C, Gupta G, et al
    Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16536.
    PubMed     Text format     Abstract available


  196. PEDROSA AF, Lisboa C, Faria-Ramos I, Silva RM, et al
    Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods.
    Br J Dermatol. 2018 Mar 5. doi: 10.1111/bjd.16521.
    PubMed     Text format     Abstract available


  197. KIM HJ, Bonciani D, Zeidi M, Pena SM, et al
    Itch in dermatomyositis: the role of increased skin interleukin-31.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16498.
    PubMed     Text format     Abstract available


  198. MELCHERS RC, Willemze R, Bekkenk MW, de Haas ERM, et al
    Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501.
    PubMed     Text format     Abstract available


  199. MARCHAND A, Tallet A, Collin C, Cormier B, et al
    A rare BRAF T599dup mutation conferring sensitivity to BRAF inhibitor in a patient with metastatic melanoma.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16499.
    PubMed     Text format     Abstract available


  200. FLEMING P
    Ixekizumab and psoriasis: an important entry into the therapeutic landscape.
    Br J Dermatol. 2018;178:585-586.
    PubMed     Text format    


  201. CAPON F
    The heterogeneous mutational landscape of pustular psoriasis.
    Br J Dermatol. 2018;178:589-590.
    PubMed     Text format    


  202. NANDA A
    Spectrum of cutaneous manifestations among patients with GATA2 deficiency.
    Br J Dermatol. 2018;178:593-594.
    PubMed     Text format    


  203. ABUABARA K, Flohr C
    Is new better than tried and tested? Topical atopic dermatitis treatment in context.
    Br J Dermatol. 2018;178:583-584.
    PubMed     Text format    


  204. BOUWES BAVINCK JN, van Zuuren EJ
    Light on fumaric acid esters therapy for psoriasis.
    Br J Dermatol. 2018;178:586-587.
    PubMed     Text format    


  205. TSAI YC
    Image Gallery: Contact dermatitis resulting from tarantula-hair injury mimicking ischaemia: a case with dermoscopy follow-up.
    Br J Dermatol. 2018;178:e227.
    PubMed     Text format    


  206. BARRAGAN-ESTUDILLO ZF, Jesus-Silva MA, Chavez-Bourgeois MM, Brito J, et al
    Image Gallery: Transition pattern in acral melanoma.
    Br J Dermatol. 2018;178:e225.
    PubMed     Text format    


    February 2018
  207. PAPP KA, Gordon KB, Langley RG, Lebwohl MG, et al
    Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3.
    Br J Dermatol. 2018 Feb 28. doi: 10.1111/bjd.16464.
    PubMed     Text format     Abstract available


  208. KIM Y, Cho JY, Oh SW, Kang M, et al
    Globular adiponectin acts as a melanogenic signal in human epidermal melanocytes.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16488.
    PubMed     Text format     Abstract available


  209. ENGEBRETSEN KA, Kezic S, Jakasa I, Hedengran A, et al
    Effect of atopic skin stressors on natural moisturizing factors and cytokines in healthy adult epidermis.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16487.
    PubMed     Text format     Abstract available


  210. STROBEL SB, Safferling K, Lahrmann B, Hoffmann JH, et al
    Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16477.
    PubMed     Text format     Abstract available


  211. NARLA S, Silverberg JI
    Association between childhood atopic dermatitis, cutaneous, extracutaneous and systemic infections.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16482.
    PubMed     Text format     Abstract available


  212. HUNTER HJA, Morsman E, Mellody KT, Ogden SK, et al
    Acute psychosocial stress downregulates N-Methyl-d-aspartate receptors (NMDAR) in healthy human skin.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16466.
    PubMed     Text format     Abstract available


  213. ORLOWSKA D, Selman LE, Beynon T, Radcliffe E, et al
    "It's a traumatic illness, traumatic to witness." A qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16447.
    PubMed     Text format     Abstract available


  214. KOTTNER J, Jacobi L, Hahnel E, Alam M, et al
    Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
    Br J Dermatol. 2018 Feb 14. doi: 10.1111/bjd.16324.
    PubMed     Text format     Abstract available


  215. KYRIAKOU A, Patsatsi A, Sotiriadis D, Goulis DG, et al
    Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16437.
    PubMed     Text format     Abstract available


  216. MORTON CA, Dominicus R, Radny P, Dirschka T, et al
    A randomized, multi-national, non-inferiority, phase III trial to evaluate the safety and efficacy of BF-200 ALA gel versus MAL cream in the treatment of non-aggressive basal cell carcinoma with photodynamic therapy (PDT).
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16441.
    PubMed     Text format     Abstract available


  217. LONGO C, Lallas A, Kyrgidis A, Bassoli S, et al
    Wide skin markings pattern - melanoma descriptor or patient-related factor?: reply from authors.
    Br J Dermatol. 2018 Feb 7. doi: 10.1111/bjd.16430.
    PubMed     Text format     Abstract available


  218. RISHPON A, Marchetti M, Marghoob A
    Wide skin markings pattern - melanoma descriptor or patient-related factor?
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16420.
    PubMed     Text format     Abstract available


  219. VILLARREAL-MARTINEZ A, Bennassar A, Gonzalez S, Malvehy J, et al
    Application of in vivo reflectance confocal microscopy (RCM) and ex vivo fluorescence confocal microscopy (FCM) in most common subtypes of Basal Cell Carcinoma and correlation with histopathology.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16421.
    PubMed     Text format     Abstract available


  220. LANGLEY RG, Papp K, Gooderham M, Zhang L, et al
    Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P).
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16426.
    PubMed     Text format     Abstract available


  221. FUJISAWA Y, Yoshino K, Otsuka A, Funakoshi T, et al
    Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16427.
    PubMed     Text format     Abstract available


  222. TSAKOK T, Jabbar-Lopez ZK, Smith CH
    Subcutaneous methotrexate in patients with moderate to severe psoriasis: a critical appraisal.
    Br J Dermatol. 2018 Feb 5. doi: 10.1111/bjd.16424.
    PubMed     Text format     Abstract available


  223. ZHANG G, Chen H, Gao Y, Liu Y, et al
    Sirolimus for treatment of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: A retrospective cohort study.
    Br J Dermatol. 2018 Feb 1. doi: 10.1111/bjd.16400.
    PubMed     Text format     Abstract available


  224. DANDO EE, Lim GFS, Ho J, James A, et al
    Image Gallery: Pigmented mammary Paget disease: a rare clinicopathological variant mimicking melanoma.
    Br J Dermatol. 2018;178:e143.
    PubMed     Text format    


  225. RAPHAEL AP, Soyer HP
    Automated diagnosis: shedding the light on skin cancer.
    Br J Dermatol. 2018;178:331-333.
    PubMed     Text format    


  226. CUST AE
    Prognostic features for acral lentiginous melanoma.
    Br J Dermatol. 2018;178:311-312.
    PubMed     Text format    


  227. RENCZ F
    Impact of dupilumab on health-related quality of life in patients with atopic dermatitis.
    Br J Dermatol. 2018;178:319-320.
    PubMed     Text format    


  228. BISSONNETTE R
    JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
    Br J Dermatol. 2018;178:321.
    PubMed     Text format    


  229. MICALI G, Lacarrubba F
    Standardized classification tools in dermatology: time to focus on cutaneous warts.
    Br J Dermatol. 2018;178:330.
    PubMed     Text format    


  230. BELL KJL, Cust AE
    Beyond country-specific incidence and mortality: the global burden of melanoma.
    Br J Dermatol. 2018;178:315-316.
    PubMed     Text format    


  231. BALATO A, Raimondo A
    Novel interactions among ultraviolet B, skin and adipose tissue.
    Br J Dermatol. 2018;178:327-328.
    PubMed     Text format    


    January 2018
  232. WANG R, Dunlap RR, Darwish MA, Simpson EL, et al
    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.
    Br J Dermatol. 2018 Jan 30. doi: 10.1111/bjd.16398.
    PubMed     Text format     Abstract available


  233. KHOURY LR, Moller T, Zachariae C, Skov L, et al
    A prospective 52-week randomised controlled trial of patient-initiated care consultations for patients with psoriasis.
    Br J Dermatol. 2018 Jan 24. doi: 10.1111/bjd.16369.
    PubMed     Text format     Abstract available


  234. BORSARI S, Pampena R, Benati E, Bombonato C, et al
    In vivo dermoscopic and confocal microscopy multi-step algorithm to detect in situ melanomas.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16364.
    PubMed     Text format     Abstract available


  235. STULL DE, Griffiths CEM, Gilloteau I, Zhao Y, et al
    Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16366.
    PubMed     Text format     Abstract available


  236. CHABY G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, et al
    Severe cutaneous adverse reactions due to inappropriate medication use.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16365.
    PubMed     Text format     Abstract available


  237. MARONAS-JIMENEZ L, Ortiz-Romero PL
    Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16374.
    PubMed     Text format     Abstract available


  238. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available


  239. GRILL C, Laila B, Rubod A, Aktary Z, et al
    Epidermal melanocytes of segmental vitiligo show altered expression of E-cadherin, but not P-cadherin.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16352.
    PubMed     Text format     Abstract available


  240. DIZON MP, Yu AM, Singh RK, Wan J, et al
    Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16340.
    PubMed     Text format     Abstract available


  241. DE BRUIN-WELLER M, Graham NMH, Pirozzi G, Shumel B, et al
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16348.
    PubMed     Text format     Abstract available


  242. BACHELEZ H
    Pustular psoriasis and related pustular skin diseases.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16232.
    PubMed     Text format     Abstract available


  243. THYSSEN JP
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with demodex and increased IL-17 levels?
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16330.
    PubMed     Text format     Abstract available


  244. KOTB IS, Lewis BJ, Barker RN, Ormerod AD, et al
    Differential effects of phototherapy, adalimumab and betamethasone/calcipotriol on effector and regulatory T cells in psoriasis.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16336.
    PubMed     Text format     Abstract available


  245. YOSHIDA H, Nagaoka A, Komiya A, Aoki M, et al
    Reduction of hyaluronan and increased expression of HYBID (KIAA1199) correlate with clinical symptoms in photoaged skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16335.
    PubMed     Text format     Abstract available


  246. SEO HM, Moon GT, Song YM, Gee HY, et al
    Expression of YAP and TAZ in molluscum contagiosum virus infected skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16333.
    PubMed     Text format     Abstract available


  247. GRIFFITHS CEM, Jo SJ, Naldi L, Romiti R, et al
    A multidimensional assessment of the burden of psoriasis: Results from a multinational dermatologist and patient survey.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16332.
    PubMed     Text format     Abstract available


  248. RANDA H, Lomholt JJ, Skov L, Zachariae R, et al
    Health-Related Quality of Life in adolescents with psoriasis: an interview-based study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16326.
    PubMed     Text format     Abstract available


  249. BEECKMAN D, Van den Bussche K, Alves P, Arnold Long MC, et al
    Towards an international language for Incontinence-Associated Dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorisation Tool (GLOBIAD) in 30 countries.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16327.
    PubMed     Text format     Abstract available


  250. LAINO AM, Berry EG, Jagirdar K, Lee KJ, et al
    Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16323.
    PubMed     Text format     Abstract available


  251. THOMSON J, Wernham AGH, Williams HC
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Br J Dermatol. 2018 Jan 6. doi: 10.1111/bjd.16317.
    PubMed     Text format     Abstract available


  252. LEWIS FM, Tatnall FM, Velangi SS, Bunker CB, et al
    British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018 Jan 4. doi: 10.1111/bjd.16241.
    PubMed     Text format     Abstract available


  253. TSCHANDL P, Wiesner T
    Advances in the diagnosis of pigmented skin lesions.
    Br J Dermatol. 2018;178:9-11.
    PubMed     Text format    


  254. VERYKIOU S, Edwards N, Hill D
    How breakthroughs in translational research have impacted treatment strategies for melanoma.
    Br J Dermatol. 2018;178:5-8.
    PubMed     Text format    


  255. CHASSET F, Haroche J
    Cutaneous manifestations of paediatric Erdheim-Chester disease, a histiocytosis of the 'L' group.
    Br J Dermatol. 2018;178:31-32.
    PubMed     Text format    


  256. PRINSEN CAC
    T-QoL: a quality of life outcome measure specifically developed for adolescents with skin diseases.
    Br J Dermatol. 2018;178:23-25.
    PubMed     Text format    


  257. SANCLEMENTE G
    What can we learn from psoriasis pharmacogenomics research?
    Br J Dermatol. 2018;178:17.
    PubMed     Text format    


  258. MILLINGTON GWM, Collins A, Lovell CR, Leslie TA, et al
    British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018.
    Br J Dermatol. 2018;178:34-60.
    PubMed     Text format    


  259. MUTHIAH S, Tang D, Nasr B, Verykiou S, et al
    A new era in holistic care: bridging the gap between dermatologists and oncologists for the treatment of malignant melanoma.
    Br J Dermatol. 2018;178:1-4.
    PubMed     Text format    


  260. RENCZ F
    Patients with psoriasis on a new trajectory: long-term improvement in quality of life with biologics.
    Br J Dermatol. 2018;178:29-30.
    PubMed     Text format    


  261. WIESNER T, Zbyszewski A
    Progress in the diagnosis and therapy of melanoma.
    Br J Dermatol. 2018;178:12-14.
    PubMed     Text format    


  262. NALDI L
    Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.
    Br J Dermatol. 2018;178:19.
    PubMed     Text format    


  263. SILLING S, Akgul B
    Treatment success in cutaneous warts: morphology and human papillomavirus type matter.
    Br J Dermatol. 2018;178:30-31.
    PubMed     Text format    


  264. SEKHON S, Koo J
    Indirubin: a novel topical agent in the treatment of psoriasis.
    Br J Dermatol. 2018;178:21.
    PubMed     Text format    


  265. WEHNER MR
    Sunscreen and melanoma prevention: evidence and expectations.
    Br J Dermatol. 2018;178:15-16.
    PubMed     Text format    


    December 2017
  266. MCINERNEY-LEO AM, Wheeler L, Sturm RA, Tan JM, et al
    Point mutation in p14(ARF) -specific exon 1beta of CDKN2A causing familial melanoma and astrocytoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16275.
    PubMed     Text format     Abstract available


  267. DE UNAMUNO BUSTOS B, Murria Estal R, Perez Simo G, Simarro Farinos J, et al
    Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16254.
    PubMed     Text format     Abstract available


  268. AAREBROT AK, Solberg SM, Davies R, Bader LI, et al
    Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16269.
    PubMed     Text format     Abstract available


  269. KRASUSKA M, Lavda AC, Thompson AR, Millings A, et al
    The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16268.
    PubMed     Text format     Abstract available


  270. SALOMON G, Maza A, Boulinguez S, Paul C, et al
    Efficacy of anti-PD-1 on skin carcinomas and melanoma metastases in an Xeroderma Pigmentosum patient.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16270.
    PubMed     Text format     Abstract available


  271. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Reply to: "An exploratory study using framework analysis to investigate health-seeking behaviour in patients with psoriasis".
    Br J Dermatol. 2017 Dec 22. doi: 10.1111/bjd.16266.
    PubMed     Text format     Abstract available


  272. GHETTI M, Topouzi H, Theocharidis G, Papa V, et al
    Sub-Populations of Dermal Skin Fibroblasts Secrete Distinct Extracellular Matrix: Implications for Using Skin Substitutes in the Clinic.
    Br J Dermatol. 2017 Dec 20. doi: 10.1111/bjd.16255.
    PubMed     Text format     Abstract available


  273. TSAI TF, Weng HJ, Wang TS
    Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series.
    Br J Dermatol. 2017 Dec 19. doi: 10.1111/bjd.16252.
    PubMed     Text format     Abstract available


  274. SVENSSON A, Ofenloch RF, Bruze M, Naldi L, et al
    Prevalence of skin disease in a population based sample of adults out of five European countries.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16248.
    PubMed     Text format     Abstract available


  275. KLIJN SL, van den Reek JMPA, van de Wetering G, van der Kolk A, et al
    Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16247.
    PubMed     Text format     Abstract available


  276. DE WIT J, Totte JEE, van Buchem FJM, Pasmans SGMA, et al
    The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16251.
    PubMed     Text format     Abstract available


  277. KAMSTRUP MR, Skov L, Zachariae C, Thyssen JP, et al
    Psoriasis and risk of malignant lymphoma: A population-based cohort study.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16245.
    PubMed     Text format     Abstract available


  278. OLSEN CM, Wilson LF, Green AC, Biswas N, et al
    How many melanomas might be prevented if more people applied sunscreen regularly?
    Br J Dermatol. 2017 Dec 14. doi: 10.1111/bjd.16079.
    PubMed     Text format     Abstract available


  279. GERBENS LAA, Hamann SAS, Brouwer MWD, Roekevisch E, et al
    Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial.
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16240.
    PubMed     Text format     Abstract available


  280. PRUSSICK RB, Miele L
    Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16239.
    PubMed     Text format     Abstract available


  281. NEMOTO O, Hirose K, Shibata S, Li K, et al
    Safety and Efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study.
    Br J Dermatol. 2017 Dec 9. doi: 10.1111/bjd.16236.
    PubMed     Text format     Abstract available


  282. THYSSEN JP, Halling-Overgaard AS, Andersen YMF, Gislason G, et al
    The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 6. doi: 10.1111/bjd.16215.
    PubMed     Text format     Abstract available


  283. AHMED A, Solman L, Williams HC
    Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.
    Br J Dermatol. 2017 Dec 3. doi: 10.1111/bjd.16046.
    PubMed     Text format     Abstract available


  284. EATON LH, Mellody KT, Pilkington SM, Dearman RJ, et al
    Impaired Langerhans' cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17.
    Br J Dermatol. 2017 Dec 1. doi: 10.1111/bjd.16172.
    PubMed     Text format     Abstract available


  285. GONZALEZ-QUESADA A, Bastida J, Rivero-Vera JC, Piris-Pinilla MA, et al
    Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    Br J Dermatol. 2017;177:e355.
    PubMed     Text format    


  286. TOLLEFSON M, Siegel D
    Advancing paediatric psoriasis treatment options for children.
    Br J Dermatol. 2017;177:1470-1471.
    PubMed     Text format    


  287. SCARISBRICK JJ
    Brentuximab vedotin is an effective therapy for CD30(+) mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Br J Dermatol. 2017;177:1474-1475.
    PubMed     Text format    


  288. LAIMER M
    MAPK14 as candidate for genetic susceptibility to diabetic foot ulcer.
    Br J Dermatol. 2017;177:1482-1483.
    PubMed     Text format    


  289. LUO Y, Liu J
    Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant.
    Br J Dermatol. 2017;177:e353.
    PubMed     Text format    


  290. KIRBY B
    Worldwide perspective of biosimilars for psoriasis.
    Br J Dermatol. 2017;177:1473.
    PubMed     Text format    


  291. VILLANI R, Khosrotehrani K
    Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma.
    Br J Dermatol. 2017;177:1472-1473.
    PubMed     Text format    


  292. GALLUCCI RM
    Transforming growth factor-beta and psoriasis: a new link.
    Br J Dermatol. 2017;177:1480-1481.
    PubMed     Text format    


    November 2017
  293. TOTTE JEE, Pardo LM, Fieten KB, de Wit J, et al
    The IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16153.
    PubMed     Text format     Abstract available


  294. PALLER AS
    Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16047.
    PubMed     Text format    


  295. DE BRUIN-WELLER M, Thaci D, Smith CH, Reich K, et al
    Dupilumab with concomitant topical corticosteroids in adult patients with atopic dermatitis who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo-controlled, randomized ph
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16156.
    PubMed     Text format     Abstract available


  296. CHAN SA, Wernham AGH, Stembridge N, Harper N, et al
    Do perioperative antibiotics reduce the risk of surgical site infections following excision of ulcerated skin cancers? a critically appraised topic.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16157.
    PubMed     Text format     Abstract available


  297. HOLMES J, von Braunmuhl T, Berking C, Sattler E, et al
    Optical coherence tomography of basal cell carcinoma: influence of location, subtype, observer variability and image quality on diagnostic performance.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16154.
    PubMed     Text format     Abstract available


  298. CHENG L, Sun B, Xiong Y, Hu L, et al
    The minor allele HCP5 rs3099844 A, PSORS1C1 rs3131003 G are associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese: a multicentre retrospective case-control clinical study.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16151.
    PubMed     Text format     Abstract available


  299. RUFF SMD, Engebretsen KA, Zachariae C, Johansen JD, et al
    The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16147.
    PubMed     Text format     Abstract available


  300. WARREN RB, Brnabic A, Saure D, Langley RG, et al
    Matching-Adjusted Indirect Comparison of Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab Versus Secukinumab.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16140.
    PubMed     Text format     Abstract available


  301. DING S, Chen J, Zeng Q, Lu J, et al
    Chronic sun exposure is associated with distinct histone acetylation changes in human skin.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16129.
    PubMed     Text format     Abstract available


  302. KANG EG, Wu S, Gupta A, von Mackensen YL, et al
    A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16131.
    PubMed     Text format     Abstract available


  303. VASSEUR P, Pohin M, Jegou JF, Favot L, et al
    Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16137.
    PubMed     Text format     Abstract available


  304. MARONAS-JIMENEZ L, Estrach T, Gallardo F, Perez A, et al
    Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16128.
    PubMed     Text format     Abstract available


  305. WINSLOW UC, Nordestgaard BG, Afzal S
    High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of 97849 individuals.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16127.
    PubMed     Text format     Abstract available


  306. STOFFEL E, Maier H, Riedl E, Bruggen MC, et al
    Analysis of anti-TNF-induced skin lesions reveals strong Th1 activation with some distinct immunological characteristics.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16126.
    PubMed     Text format     Abstract available


  307. SNAST I, Reiter O, Atzmony L, Leshem YA, et al
    Psychological stress and psoriasis. A systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 9. doi: 10.1111/bjd.16116.
    PubMed     Text format     Abstract available


  308. TZANEVA S, Geroldinger A, Trattner H, Tanew A, et al
    Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy in patients with moderate to severe plaque psoriasis: A randomized prospective clinical stud
    Br J Dermatol. 2017 Nov 8. doi: 10.1111/bjd.16106.
    PubMed     Text format     Abstract available


  309. BURDEN-TEH E, Phillips RC, Thomas KS, Ratib S, et al
    A systematic review of diagnostic criteria for psoriasis in adults and children: Evidence from studies with a primary aim to develop or validate diagnostic criteria.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16104.
    PubMed     Text format     Abstract available


  310. DEL PUERTO C, Navarrete-Dechent C, Molgo M, Camargo CA Jr, et al
    Immunohistochemical expression of vitamin D receptor in melanocytic nevi and cutaneous melanoma. A case-control study.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16103.
    PubMed     Text format     Abstract available


  311. EGEBERG A, Ottosen MB, Gniadecki R, Broesby-Olsen S, et al
    Safety, efficacy, and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2017 Nov 1. doi: 10.1111/bjd.16102.
    PubMed     Text format     Abstract available


  312. FINLAY AY
    Real-world effect of biologics on quality of life in psoriasis.
    Br J Dermatol. 2017;177:1164-1165.
    PubMed     Text format    


  313. ROH MR
    Role of endothelial dysfunction in pathological cutaneous scarring.
    Br J Dermatol. 2017;177:1153.
    PubMed     Text format    


  314. FLORENCE L, Fuller LC
    Washing with water and glycerine improves skin barrier function and quality of life in patients with podoconiosis.
    Br J Dermatol. 2017;177:1166.
    PubMed     Text format    


  315. LUO Y, Liu J
    Image Gallery: Moth-eaten alopecia as the only cutaneous symptom of acquired secondary syphilis in a 2-year-old boy.
    Br J Dermatol. 2017;177:e227.
    PubMed     Text format    


  316. DANBY SG
    Staphylococcus aureus in atopic dermatitis: a diverse problem?
    Br J Dermatol. 2017;177:1164.
    PubMed     Text format    


  317. DRUCKER AM
    Making sense of measures of clinical signs for atopic dermatitis.
    Br J Dermatol. 2017;177:1158-1159.
    PubMed     Text format    


  318. SILVERBERG JI
    Are moisturizers effective in the treatment of atopic dermatitis?
    Br J Dermatol. 2017;177:1154.
    PubMed     Text format    


  319. HARWOOD CA, Arron ST, Proby CM, Asgari MM, et al
    Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.
    Br J Dermatol. 2017;177:1150-1151.
    PubMed     Text format    


  320. RAZMI T M, De D, Handa S, Saikia UN, et al
    Image Gallery: Generalized circinate cutaneous lesions simulating circinate balanitis.
    Br J Dermatol. 2017;177:e224.
    PubMed     Text format    


  321. HAMMER K, Hugel R, Lange-Asschenfeldt B, Painsi C, et al
    Image Gallery: Cutaneous signs of acute pancreatitis.
    Br J Dermatol. 2017;177:e222.
    PubMed     Text format    


    October 2017
  322. GRANDO SA, Zachary CB
    THE NON-NEURONAL AND NON-MUSCULAR EFFECTS OF BOTULINUM TOXIN: A Graceful Opportunity for a Deadly Molecule to Treat a Human Disease in the Skin and Beyond.
    Br J Dermatol. 2017 Oct 31. doi: 10.1111/bjd.16080.
    PubMed     Text format     Abstract available


  323. HARWOOD CA, Toland AE, Proby CM, Euvrard S, et al
    The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients.
    Br J Dermatol. 2017 Oct 30. doi: 10.1111/bjd.15956.
    PubMed     Text format     Abstract available


  324. BLOMBERG M, He SY, Harwood C, Arron ST, et al
    Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Br J Dermatol. 2017 Oct 30. doi: 10.1111/bjd.15950.
    PubMed     Text format     Abstract available


  325. DIXON LJ, Witcraft SM, McCowan NK, Brodell RT, et al
    Stress and Skin Disease Quality of Life: The Moderating Role of Anxiety Sensitivity Social Concerns.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16082.
    PubMed     Text format     Abstract available


  326. CORDEL N, Hebert V, Vega Rua A, Herrmann-Storck C, et al
    In vivo Zika virus detection in human skin.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16096.
    PubMed     Text format     Abstract available


  327. STAIMAN A, Hsu DY, Silverberg JI
    Epidemiology of Staphylococcal Scalded Skin Syndrome in United States Children.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16097.
    PubMed     Text format     Abstract available


  328. EGGEN CAM, Lommerts JE, van Zuuren EJ, Limpens J, et al
    Laser treatment of congenital melanocytic nevi: a systematic review.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16094.
    PubMed     Text format     Abstract available


  329. TRAN AD, Fogarty G, Nowak AK, Espinoza D, et al
    A systematic review and meta-analysis of utility estimates in melanoma.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16098.
    PubMed     Text format     Abstract available


  330. CHEN L, Tsai TF
    HLA-Cw6 and psoriasis.
    Br J Dermatol. 2017 Oct 26. doi: 10.1111/bjd.16083.
    PubMed     Text format     Abstract available


  331. LANGAN EA, Griffiths CEM, Solbach W, Knobloch JK, et al
    The role of the microbiome in psoriasis: moving from disease description to treatment prediction?
    Br J Dermatol. 2017 Oct 26. doi: 10.1111/bjd.16081.
    PubMed     Text format     Abstract available


  332. VAKHARIA PP, Chopra R, Sacotte R, Patel N, et al
    Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16078.
    PubMed     Text format     Abstract available


  333. SEO JW, Ha SM, Song KH
    Insulin-Like Growth Factor-II mRNA-Binding Protein 3 as a Novel Prognostic Biomarker for Acral Lentiginous Melanoma.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16077.
    PubMed     Text format     Abstract available


  334. GELLER S, Myskowski PL, Kim YH, Moskowitz A, et al
    The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: Are we there yet?
    Br J Dermatol. 2017 Oct 10. doi: 10.1111/bjd.16052.
    PubMed     Text format     Abstract available


  335. STROBER BE, Langley RGB, Menter A, Magid M, et al
    No Elevated Risk for Depression, Anxiety, or Suicidality with Secukinumab in a Pooled Analysis of Data from 10 Clinical Studies in Moderate-to-Severe Plaque Psoriasis.
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16051.
    PubMed     Text format     Abstract available


  336. PAPP KA, Leonardi CL, Blauvelt A, Reich K, et al
    Ixekizumab treatment for psoriasis: Integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3).
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16050.
    PubMed     Text format     Abstract available


  337. RUNGAPIROMNAN W, Yiu ZZN, Warren RB, Griffiths CEM, et al
    Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials': reply from the authors.
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16043.
    PubMed     Text format     Abstract available


  338. BASSOLI S, Kyrgidis A, Ciardo S, Casari A, et al
    Uncovering the diagnostic dermoscopic features of flat melanomas located on the lower limbs.
    Br J Dermatol. 2017 Oct 7. doi: 10.1111/bjd.16030.
    PubMed     Text format     Abstract available


  339. VALLERAND IA, Patten SB
    Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship.
    Br J Dermatol. 2017 Oct 3. doi: 10.1111/bjd.16018.
    PubMed     Text format     Abstract available


  340. NGUYEN MO, Nguyen HT, Asgari MM
    Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients.
    Br J Dermatol. 2017;177:901-902.
    PubMed     Text format    


  341. EGEBERG A
    Cardiometabolic disease in atopic dermatitis: the heart of the matter.
    Br J Dermatol. 2017;177:898-899.
    PubMed     Text format    


  342. SCHAIDER H, Sturm RA
    The evolving universe of BRAF mutations in melanoma.
    Br J Dermatol. 2017;177:893.
    PubMed     Text format    


  343. EGEBERG A
    Getting tired of psoriasis?
    Br J Dermatol. 2017;177:899-900.
    PubMed     Text format    


  344. HOFMANN H
    A foot tumour as late cutaneous Lyme borreliosis: a new entity or a variant of an inflammatory proliferative reaction to Borrelia burgdorferi?
    Br J Dermatol. 2017;177:906-907.
    PubMed     Text format    


  345. HAY R
    Staphylococcus aureus and psoriasis: time for a re-appraisal?
    Br J Dermatol. 2017;177:894-895.
    PubMed     Text format    


  346. ROBINSON JK, Spring B
    Personalized melanoma genomic risk information:perception of shared risk initiates sharing with family.
    Br J Dermatol. 2017;177:890-891.
    PubMed     Text format    


  347. ZYCHOWSKA M, Maj J
    Image Gallery: Cutaneous metastases from hidden carcinoma of the penis.
    Br J Dermatol. 2017;177:e161.
    PubMed     Text format    


  348. SODERLUND-VENERMO M
    Clinical significance of parvovirus B19 DNA in cutaneous biopsies.
    Br J Dermatol. 2017;177:900-901.
    PubMed     Text format    


  349. BALAK DMW
    First-line systemic treatment of psoriasis: staying conventional or going biologic?
    Br J Dermatol. 2017;177:897-898.
    PubMed     Text format    


  350. CHU L, Zhang M, Ran Y
    Further progress for therapeutic solutions in psoriasis.
    Br J Dermatol. 2017;177:896-897.
    PubMed     Text format    


  351. SEMINARA NM, Pomeranz MK
    Unravelling the links between malignancy, cytokines and neutrophilic eruptions.
    Br J Dermatol. 2017;177:905-906.
    PubMed     Text format    


  352. ASERO R
    Towards a better categorization of patients with chronic urticaria.
    Br J Dermatol. 2017;177:903-904.
    PubMed     Text format    


  353. TAN J
    Acne guidelines: pearls, pitfalls and questions.
    Br J Dermatol. 2017;177:892-893.
    PubMed     Text format    


  354. YUAN H, Pan M
    Endoscopic characteristics of oesophagus involvement in mucous membrane pemphigoid.
    Br J Dermatol. 2017;177:902-903.
    PubMed     Text format    


  355. BETZ RC
    A path through the reticulate pigmentation disorder jungle.
    Br J Dermatol. 2017;177:893-894.
    PubMed     Text format    


  356. VOSSEN ARJV, van der Zee HH, Prens EP
    Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms.
    Br J Dermatol. 2017;177:895-896.
    PubMed     Text format    


    September 2017
  357. NAKAGAWA H, Nemoto O, Igarashi A, Nagata T, et al
    Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study.
    Br J Dermatol. 2017 Sep 28. doi: 10.1111/bjd.16014.
    PubMed     Text format     Abstract available


  358. SCHMIEDER GJ, Draelos ZD, Pariser DM, Banfield C, et al
    Efficacy and safety of the Janus Kinase 1 inhibitor PF-04965842 in patients with moderate to severe psoriasis: phase 2, randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2017 Sep 26. doi: 10.1111/bjd.16004.
    PubMed     Text format     Abstract available


  359. HOGENDOORN GK, Bruggink SC, Hermans KE, Kouwenhoven STP, et al
    Developing and validating the CWARTS diagnostic tool, a novel clinical assessment and classification system for cutaneous warts.
    Br J Dermatol. 2017 Sep 26. doi: 10.1111/bjd.15999.
    PubMed     Text format     Abstract available


  360. NOREN P, Hagstromer L, Alimohammadi M, Melin L, et al
    The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.
    Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009.
    PubMed     Text format     Abstract available


  361. GORDON KB, Blauvelt A, Foley P, Song M, et al
    Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the Phase 3 VOYAGE 1 and VOYAGE 2 studies.
    Br J Dermatol. 2017 Sep 22. doi: 10.1111/bjd.16008.
    PubMed     Text format     Abstract available


  362. MAGLIE R, Di Cesare A, Lazzeri L, Pescitelli L, et al
    Lichen Planus triggered by infliximab biosimilar CT-P13 and recurred during secukinumab treatment.
    Br J Dermatol. 2017 Sep 22. doi: 10.1111/bjd.16003.
    PubMed     Text format     Abstract available


  363. MACARTHUR KM, Cohen BA
    Tailoring Diagnostic Studies in Hand, Foot, and Mouth Disease: Utility of PCR testing of Lesional Skin.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15991.
    PubMed     Text format     Abstract available


  364. SIGURGEIRSSON B, Luger T
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15849.
    PubMed     Text format    


  365. NAGTZAAM IF, Peeters VPM, Vreeburg M, Wagner A, et al
    Novel CLDN1 mutation in ichthyosis-hypotrichosis-sclerosing-cholangitis syndrome without signs of liver disease.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15996.
    PubMed     Text format     Abstract available


  366. HIETIKKO M, Hervonen K, Salmi T, Ilus T, et al
    Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of dermatitis herpetiformis patients after a long-term gluten-free diet.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15995.
    PubMed     Text format     Abstract available


  367. HOTZ A, Fagerberg C, Vahlquist A, Bygum A, et al
    Identification of Mutations in SDR9C7 in 6 Families with Autosomal Recessive Congenital Ichthyosis.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15994.
    PubMed     Text format     Abstract available


  368. MAJEED-ARISS R, McPhee M, Bundy C, Griffiths CEM, et al
    Developing a protocol to identify and prioritise research questions for psoriasis: A James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15992.
    PubMed     Text format     Abstract available


  369. CHEE SN, Novakovic L, Fassihi H, Garibaldinos T, et al
    Chronic actinic dermatitis: successful treatment with PUVA photochemotherapy.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15969.
    PubMed     Text format     Abstract available


  370. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available


  371. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available


  372. EGEBERG A, Nast A
    The value and pitfalls of biologics registries for psoriasis.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15971.
    PubMed     Text format     Abstract available


  373. CORK MJ, Danby SG
    The British Skin Foundation: 20 years of supporting dermatology research.
    Br J Dermatol. 2017;177:608-609.
    PubMed     Text format    


  374. QU H, Zhao Z, Yu J
    Image Gallery: Cutaneous presentation of disseminated cryptococcosis in a patient with undiagnosed HIV infection.
    Br J Dermatol. 2017;177:e73.
    PubMed     Text format    


  375. PRINSEN CAC
    Changing patients' understanding of psoriasis is promising.
    Br J Dermatol. 2017;177:616-617.
    PubMed     Text format    


  376. ROTA M
    Evidence for an association between alcohol intake and an increased risk of nonmelanoma skin cancer.
    Br J Dermatol. 2017;177:611-612.
    PubMed     Text format    


  377. ZNAOR A
    Melanoma burden, healthcare utilization and the potential for overdiagnosis in the elderly U.S. population.
    Br J Dermatol. 2017;177:625.
    PubMed     Text format    


  378. GISONDI P
    High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema.
    Br J Dermatol. 2017;177:606-607.
    PubMed     Text format    


  379. COWDELL F
    Health-seeking behaviour in people with psoriasis.
    Br J Dermatol. 2017;177:615-616.
    PubMed     Text format    


  380. DOBREV H
    Organization of the dermal matrix impacts the biomechanical properties of skin.
    Br J Dermatol. 2017;177:622-623.
    PubMed     Text format    


  381. PUIG L
    Choice of first-line biologic therapy in psoriasis: understanding the past and shaping the future?
    Br J Dermatol. 2017;177:623-624.
    PubMed     Text format    


  382. QU H, Song Y, Li R, Yu J, et al
    Image Gallery: An unusual cutaneous presentation of disseminated penicilliosis marneffei in an immunocompetent patient.
    Br J Dermatol. 2017;177:e67.
    PubMed     Text format    


  383. HABER R, Bourrat E, Derache AF, Rivet J, et al
    Image Gallery: Juvenile cutaneous chronic graft-versus-host disease presenting as bullous pemphigoid.
    Br J Dermatol. 2017;177:e69.
    PubMed     Text format    


  384. EMTESTAM L, Sartorius K
    Glucagon-like peptide-1 agonists for treatment of hidradenitis suppurativa.
    Br J Dermatol. 2017;177:625-627.
    PubMed     Text format    


  385. SHARMA VK, Bhatia R
    Vitiligo and the psyche.
    Br J Dermatol. 2017;177:612-613.
    PubMed     Text format    


  386. PRIOR J
    Qualitative study of online discussion forums about acne.
    Br J Dermatol. 2017;177:616.
    PubMed     Text format    


  387. ARENTS BWM
    Eczema treatment: it takes time to do no harm.
    Br J Dermatol. 2017;177:613-614.
    PubMed     Text format    


  388. RAO S, Arbiser JL
    Promoting intolerance: learning from warts.
    Br J Dermatol. 2017;177:621-622.
    PubMed     Text format    


  389. TENSEN CP, Vermeer MH
    MicroRNA-155 potentiates tumour development in mycosis fungoides.
    Br J Dermatol. 2017;177:618-620.
    PubMed     Text format    


  390. HOLMES S, Harries M
    Re: Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia: reply from the authors.
    Br J Dermatol. 2017;177:884.
    PubMed     Text format    


  391. DLOVA NC, Dadzie OE
    Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia.
    Br J Dermatol. 2017;177:883-884.
    PubMed     Text format    


    August 2017
  392. MOSSNER R, Wilsmann-Theis D, Oji V, Gkogkolou P, et al
    The genetic basis for most patients with pustular skin disease remains elusive.
    Br J Dermatol. 2017 Aug 5. doi: 10.1111/bjd.15867.
    PubMed     Text format     Abstract available


  393. DAWE RS
    Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
    Br J Dermatol. 2017;177:337-338.
    PubMed     Text format    


  394. STEFANAKI C, Stratigos A
    Alopecia in Cronkhite-Canada syndrome.
    Br J Dermatol. 2017;177:348-349.
    PubMed     Text format    


  395. VIEYRA-GARCIA P, Wolf P
    Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
    Br J Dermatol. 2017;177:336-337.
    PubMed     Text format    


  396. TAN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes: reply from the author.
    Br J Dermatol. 2017;177:598-599.
    PubMed     Text format    


  397. WILKIN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes.
    Br J Dermatol. 2017;177:597-598.
    PubMed     Text format    


  398. GELLER S, Sprecher E
    IgA pemphigus: lumping or splitting?
    Br J Dermatol. 2017;177:581-582.
    PubMed     Text format    


  399. BRUNASSO AMG, Massone C
    Alitretinoin therapy for palmoplantar pustulosis.
    Br J Dermatol. 2017;177:578-579.
    PubMed     Text format    


  400. TSAKOK T, Roberts E, Bridgett C, Staughton RCD, et al
    The effectiveness of habit reversal on treatment outcome and quality of life in patients with chronic eczema: a prospective observational study in the U.K.
    Br J Dermatol. 2017;177:554-556.
    PubMed     Text format    


    July 2017
  401. BAGOT M
    Folliculotropic mycosis fungoides is a heterogenous group.
    Br J Dermatol. 2017;177:17-18.
    PubMed     Text format    


  402. HAMMERS CM, Payne AS
    Clinical significance of immunoglobulin E in bullous pemphigoid.
    Br J Dermatol. 2017;177:13-14.
    PubMed     Text format    


  403. DAWE RS, McGuire VA
    Mild classical xeroderma pigmentosum.
    Br J Dermatol. 2017;177:21-22.
    PubMed     Text format    


  404. CALZAVARA-PINTON PG, Caravello S
    A practical approach to the initial dose and subsequent increments for ultraviolet A1 phototherapy.
    Br J Dermatol. 2017;177:19-20.
    PubMed     Text format    


  405. HATTA N
    New technology discloses the tumour margin of extramammary Paget disease?
    Br J Dermatol. 2017;177:18-19.
    PubMed     Text format    


  406. CHONG BF
    Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis.
    Br J Dermatol. 2017;177:9-10.
    PubMed     Text format    


  407. MAHER NG, Guitera P
    Imiquimod treatment for lentigo maligna: LIMIT-1 trial.
    Br J Dermatol. 2017;177:324-325.
    PubMed     Text format    


  408. STRAZZULLA LC, Avila L, Lo Sicco K, Shapiro J, et al
    Response to 'Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens'.
    Br J Dermatol. 2017;177:323.
    PubMed     Text format    


    June 2017
  409. ITO T
    Immune checkpoint inhibitor-associated alopecia areata.
    Br J Dermatol. 2017;176:1444-1445.
    PubMed     Text format    


  410. MURPHY M, Carmichael AJ
    Development of a multidimensional assessment tool for uraemic pruritus in dialysis patients - laying a foundation stone for itch research.
    Br J Dermatol. 2017;176:1432-1433.
    PubMed     Text format    


  411. BECATTI M
    Oxidative stress and high-mobility group box 1 (HMGB1) protein release in vitiligo.
    Br J Dermatol. 2017;176:1436-1437.
    PubMed     Text format    


  412. PATSATSI A, Murrell DF
    Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid.
    Br J Dermatol. 2017;176:1428-1429.
    PubMed     Text format    


  413. LEGAT FJ, Wolf P
    Daylight photodynamic therapy: where and when is it possible?
    Br J Dermatol. 2017;176:1440-1441.
    PubMed     Text format    


  414. BOWER C
    Field treatment of actinic keratosis on the scalp.
    Br J Dermatol. 2017;176:1425-1426.
    PubMed     Text format    


  415. BASU TN
    Neutrophilic eccrine hidradenitis can be induced by BRAF inhibitors.
    Br J Dermatol. 2017;176:1443-1444.
    PubMed     Text format    


  416. TWO AM
    Minocycline as an alternative to doxycycline in the treatment of rosacea.
    Br J Dermatol. 2017;176:1426.
    PubMed     Text format    


  417. MCGRATH JA
    A new clinical diagnostic matrix for epidermolysis bullosa.
    Br J Dermatol. 2017;176:1442-1443.
    PubMed     Text format    


    May 2017
  418. SCARISBRICK JJ
    Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
    Br J Dermatol. 2017;176:1129-1130.
    PubMed     Text format    


  419. BRAATHEN LR
    Long methylaminolaevulinate application does not increase clinical efficacy of photodynamic therapy in actinic keratosis, but leads to collateral damage.
    Br J Dermatol. 2017;176:1121-1122.
    PubMed     Text format    


  420. TAMURA D, Khan SG, DiGiovanna JJ
    Molecular diagnosis of xeroderma pigmentosum variant in an isolated population: the interface between precision medicine and public health.
    Br J Dermatol. 2017;176:1125-1126.
    PubMed     Text format    


  421. APFELBACHER CJ
    Research questions for the treatment of alopecia areata have been prioritized.
    Br J Dermatol. 2017;176:1128-1129.
    PubMed     Text format    


  422. CUST AE
    Estimating the future health service burden of keratinocyte cancers in the U.K.
    Br J Dermatol. 2017;176:1107-1108.
    PubMed     Text format    


  423. HASHIMOTO T, Mizoguchi A
    Interleukin-10-producing B-cells in autoimmune bullous diseases.
    Br J Dermatol. 2017;176:1119-1120.
    PubMed     Text format    


  424. LEIJTEN EFA, Sigurdsson V, Wenink MH, Radstake TRDJ, et al
    Screening for psoriatic arthritis using the Psoriasis Epidemiology Screening Tool questionnaire: examining the optimal cut-off.
    Br J Dermatol. 2017;176:1357-1359.
    PubMed     Text format    


    April 2017
  425. THOMPSON AR, Bewley AP
    Meeting the psychological needs of dermatology patients.
    Br J Dermatol. 2017;176:858-859.
    PubMed     Text format    


  426. OFENLOCH RF
    Health-related quality of life in hidradenitis suppurativa.
    Br J Dermatol. 2017;176:861-862.
    PubMed     Text format    


  427. AGNER T, Nixon R
    Hand eczema is to be taken seriously ....
    Br J Dermatol. 2017;176:854-855.
    PubMed     Text format    


  428. BROWN SJ
    Evidence-based medicine for atopic eczema: identifying the knowns and unknowns.
    Br J Dermatol. 2017;176:842-844.
    PubMed     Text format    


  429. SCHREML S, Berneburg M
    The global burden of diabetic wounds.
    Br J Dermatol. 2017;176:845-846.
    PubMed     Text format    


  430. IBBOTSON SH
    Shedding light on drug photosensitivity reactions.
    Br J Dermatol. 2017;176:850-851.
    PubMed     Text format    


  431. CHU CY
    Measuring quality of life in infants, children and adolescents with eczema.
    Br J Dermatol. 2017;176:848-849.
    PubMed     Text format    


  432. HAMPTON P, Meggitt S
    Better definition of hidradenitis suppurativa subtypes is needed to progress disease-specific treatment outcomes.
    Br J Dermatol. 2017;176:862-863.
    PubMed     Text format    


  433. STOODLEY P
    Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa.
    Br J Dermatol. 2017;176:855-856.
    PubMed     Text format    


  434. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    


  435. KWON HS, Lee JH, Kim GM, Bae JM, et al
    Image Gallery: Subcutaneous fat necrosis of the newborn.
    Br J Dermatol. 2017;176:e32.
    PubMed     Text format    


    March 2017
  436. RAMZY AG, Lammintausta K, Matura M, B Christensson J, et al
    Isothiocyanates are important as haptens in contact allergy to chloroprene rubber.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15444.
    PubMed     Text format     Abstract available


  437. FINLAY AY
    Every dermatology consultation: think adherence.
    Br J Dermatol. 2017;176:558-559.
    PubMed     Text format    


  438. MAKRYGEORGOU A
    Secukinumab shows reassuring low immunogenicity.
    Br J Dermatol. 2017;176:573-574.
    PubMed     Text format    


    February 2017
  439. SU JC, Dailey R, Zallmann M, Leins E, et al
    Determining Effects of Superfine Sheep wool in INfantile Eczema (DESSINE): a randomized paediatric cross over study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15376.
    PubMed     Text format     Abstract available


    January 2017
  440. TASANI M, Glover M, Martinez AE, Shaw L, et al
    Atenolol Treatment for Infantile Haemangioma.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15317.
    PubMed     Text format     Abstract available


  441. POLUBOTHU S, Kinsler VA
    The ethnicity profile of patients with birthmarks reveals interaction of germline and post-zygotic genetics.
    Br J Dermatol. 2017 Jan 13. doi: 10.1111/bjd.15260.
    PubMed     Text format     Abstract available


  442. DE BERKER D, McGregor JM, Mohd Mustapa MF, Exton LS, et al
    British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.
    Br J Dermatol. 2017;176:20-43.
    PubMed     Text format    


  443. FLYNN A, Molony P, Keeting C, Cullen J, et al
    Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.
    Br J Dermatol. 2017;176:e2.
    PubMed     Text format    


  444. TAN J, Steinhoff M, Berg M, Del Rosso J, et al
    Shortcomings in rosacea diagnosis and classification.
    Br J Dermatol. 2017;176:197-199.
    PubMed     Text format    


  445. TANG JQ, Ran X, Ran YP
    Cover Image: Dermoscopy in vivo for the life cycle of Phthirus pubis.
    Br J Dermatol. 2017;176:279.
    PubMed     Text format    


  446. INGRAM JR, Anstey A
    The evolution of clinical guidelines for dermatologists: GRADE, AGREE and occasionally consensus by experts.
    Br J Dermatol. 2017;176:3-4.
    PubMed     Text format    


    November 2016
  447. KOPPES SA, Ljubojevic Hadzavdic S, Jakasa I, Franceschi N, et al
    Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate.
    Br J Dermatol. 2016 Nov 4. doi: 10.1111/bjd.15163.
    PubMed     Text format     Abstract available


  448. BERENTS TL, Lodrup Carlsen KC, Mowinckel P, Skjerven HO, et al
    Transepidermal water loss in infancy associated with atopic eczema at 2 years: a population-based cohort study.
    Br J Dermatol. 2016 Nov 3. doi: 10.1111/bjd.15157.
    PubMed     Text format     Abstract available


    August 2016
  449. MOSE KF, Andersen F, Skov L, Ropke MA, et al
    Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14949.
    PubMed     Text format     Abstract available


    July 2016
  450. TULL TJ, Noy M, Bunker CB, Francis ND, et al
    Sebopsoriasis in HIV positive patients: A case series of twenty patients.
    Br J Dermatol. 2016 Jul 22. doi: 10.1111/bjd.14874.
    PubMed     Text format     Abstract available


    April 2016
  451. OREGAARD JS, Jarjis RD, Venzo A, Jemec B, et al
    Cover Image: Unique presentation of a subungual malignant melanoma in situ.
    Br J Dermatol. 2016;174:935.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: